The E3 Ubiquitin Ligase UBE3B Regulates Synaptic Development and Cortical Network Activity.
Shayal Vashisth, Aleya Shedd, Ariel Aiken and 5 others
PMID 41844341WHAT IT FOUND
Loss of UBE3B in mouse brains caused fewer vocalizations, less social interaction, impaired learning and motor coordination, and fewer excitatory synapses.
It is a genetic mouse model. No therapy was tested.
Key findings
01Removing UBE3B from the mouse CNS caused neonatal mice to emit very few, if any, ultrasonic vocalizations, and adult mice spent ~58% less time interacting with other mice.
02The knockout mice showed impaired learning and memory: they did not prefer a novel object, froze less in fear conditioning, and did not distinguish the target quadrant in the water maze.
03They also had weaker grip, poorer balance, and ~53% lower excitatory synaptic density in the cortex.
STILL TO COME
How it was doneWhat they found
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study used mice and cells, not human patients. The paper does not state how many mice were used in each experiment. Structural excitatory synapse changes were not accompanied by changes in miniature excitatory currents, so the functional consequence at synapses is not fully explained. A different conditional knockout model using Emx1-Cre showed opposite phenotypes, including increased dendritic spine density and enhanced miniature excitatory current frequency. The protein analysis used nerve stem cells from a constitutive knockout line rather than the conditional knockout mice, because the labelling method requires dividing cells. No treatment was tested, so the paper does not provide evidence that altering UBE3B function changes outcomes.
Declared interests
The authors declared no competing financial interests. The paper does not give a funding source.
The easy way to misread this
Do not read this as evidence that a therapy helps patients with Kaufman oculocerebrofacial syndrome. The study removed one gene in mouse brains and observed deficits. It did not test treatment in humans.